Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice

2022-12-01
Özcengiz, Erkan
Keser, Duygu
Özcengiz, Gülay
Çelik, Gözde
ÖZKUL, AYKUT
İnçeh, Fatma Nur
Show full item record
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
85
views
26
downloads
Coronavirus disease (COVID-19) is ongoing as a global epidemic and there is still a need to develop much safer and more effective new vaccines that can also be easily adapted to important variants of the pathogen. In the present study in this direction, we developed a new COVID-19 vaccine, composed of two critical antigenic fragments of the S1 and S2 region of severe acute respiratory syndrome coronavirus 2 as well as the whole nucleocapsid protein (N), which was formulated with either alum or alum plus monophosphoryl lipid A (MPLA) adjuvant combinations. Methods: From within the spike protein S1 region, a fragmented protein P1 (MW:33 kDa) which includes the receptor-binding domain (RBD), another fragment protein P2 (MW:17.6) which contains important antigenic epitopes within the spike protein S2 region, and N protein (MW:46 kDa) were obtained after recombinant expression of the corresponding gene regions in Escherichia coli BL21. For use in immunization studies, three proteins were adsorbed with aluminum hydroxide gel and with the combination of aluminum hydroxide gel plus MPLA. Results: Each of the three protein antigens produced strong reactions in enzyme-linked immunosorbent assays and Western blot analysis studies performed with convalescent COVID-19 patient sera. In mice, these combined protein vaccine candidates elicited high titer anti-P1, anti-P2, and anti-N IgG and IgG2a responses. These also induced highly neutralizing antibodies and elicited significant cell-mediated immunity as demonstrated by enhanced antigen-specific levels of interferon-γ (INF-γ) in the splenocytes of immunized mice. Conclusion: The results of this study showed that formulations of the three proteins with Alum or Alum + MPLA are effective in terms of humoral and cellular responses. However, since the Alum + MPLA formulation appears to be superior in Th1 response, this vaccine candidate may be recommended mainly for the elderly and immunocompromised individuals. We also believe that the alum-only formulation will provide great benefits for adults, young adolescents, and children.
COVID-19, nucleocapsid protein, receptor binding domain (RBD), recombinant subunit vaccine, SARS-CoV-2, spike protein
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85142914001&origin=inward
https://hdl.handle.net/11511/101751
Immunity, Inflammation and Disease
Department of Biology, Article

Suggestions

PRODUCTION OF VIRUS LIKE PARTICLES EXPRESSING ALPHA (B.1.1.7) OR DELTA PLUS (B.1.617.2.1) SPIKE VARIANTS AND DEVELOPMENT OF A PSEUDOTYPED VIRUS NEUTRALIZATION ASSAY
Güvençli, Neşe; Gürsel, Mayda; Department of Molecular Biology and Genetics (2022-2-10)
Vaccines are one of the most important public health interventions to combat the spread of infectious diseases. All currently approved COVID-19 vaccines target Spike antigen derived from the authentic Wuhan strain. However, with the emergence of new variants effectiveness of the current vaccines declined, commensurate to their ability to generate neutralizing antibodies against some variants of concern (VOC). Since new VOCs are predicted to emerge the next 2-4 years, variant specific vaccines are urgently n...
Assessment of the immunogenicity and formulation of recombinant proteins from SARS-CoV-2 as vaccine antigens
Keser, Duygu; Özcengiz, Gülay; Department of Biology (2022-9-15)
COVID-19 is an infectious disease caused by SARS-CoV-2. The virus was first detected in Wuhan, China in late 2019, and the outbreak was declared a pandemic in January 2020 by WHO, and continues to spread worldwide. As of July 2022, more than 575 million confirmed cases have been detected all over the world, and more than 6 million people died from the disease. One of the most important public health measures in combating the spread of infectious diseases is vaccination. Despite the existence of rapidly deve...
A PROBABILISTIC ASSESSMENT OF SARS-COV-2 HOST INTERACTIONS IN THE CONTEXT OF META-COMMUNITY AND URBAN ECOLOGY
Nehri, Leman Nur; Eroğlu, Seçkin; Department of Biology (2021-6-29)
Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that was detected in Wuhan, China, in December 2019 and spread all around the world. COVID-19 is caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which spreads through close contact. Many studies have been conducted on the transmission, virulence, and immune response of SARS-CoV-2. The intracellular mechanism of action of the virus and various host interaction pathways are also known. In addition, there are many studies on the...
Effect of UV treatment for the removal of sulfonamide resistance gene during wastewater treatment
Bulut, Taliye; İçgen, Bülent (2018-04-27)
The dissemination of the antibiotic resistance genes (ARGs) is considered as one of the most important threats to public health. This dissemination also becomes a threat for water quality in surface waters and groundwater. Waters contaminated with ARGs can easily be incorporated into human life through several ways like drinking water, agriculture and animal husbandry. Sulfonamide resistance gene, one of the ARGs, in discharged waters increases gradually because the use of these drugs is highly common. Wast...
Development and immunological evaluation of SARS-CoV-2 virus-like particles (VLP) expressing the prefusion stabilized variants of the Spike protein
İpekoğlu, Emre Mert; Gürsel, Mayda; Department of Molecular Biology and Genetics (2022-1-24)
Emergence of the COVID-19 pandemic necessitated rapid development of highly effective vaccines against SARS-CoV-2. One adaptable strategy to produce a vaccine candidate against SARS-CoV-2 is based on the exploitation of the self- assembly feature of the structural proteins of SARS-CoV-2: Spike, Membrane, Envelope and Nucleocapsid, forming Virus-like particles (VLP). Our early studies focused on laboratory-scale production of SARS-CoV-2 VLPs in a mammalian host cell system based on transient expression of vi...
Citation Formats
E. Özcengiz, D. Keser, G. Özcengiz, G. Çelik, A. ÖZKUL, and F. N. İnçeh, “Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice,” Immunity, Inflammation and Disease, vol. 10, no. 12, pp. 0–0, 2022, Accessed: 00, 2023. [Online]. Available: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85142914001&origin=inward.
METU IIS - Integrated Information Service open@metu.edu.tr